Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Neuroimmunol. 2007 Feb 27;185(1-2):168–174. doi: 10.1016/j.jneuroim.2007.01.011

Figure 3.

Figure 3

Levels of ex vivo cellular production of interferon-gamma decreased compared to baseline over the course of IFN-β therapy in the total group on any IFN-β therapy (p<0.001) and in the group of responders (p=0.013). Compared to non-responders, IFN-gamma levels were lower on treatment in responders (p=0.005). Overlapping error bars are removed for clarity.